Harvard Bioscience Aktie
-
Deine Einschätzung
Harvard Bioscience Aktie
Was spricht für und gegen Harvard Bioscience in den nächsten Jahren?
Pro
Kontra
Rendite von Harvard Bioscience im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Harvard Bioscience | - | - | - | - | - | - | - |
| Simulations Plus | -4,72 % | 3,25 % | 28,93 % | -65,68 % | -17,53 % | -65,68 % | -76,70 % |
| Fonar Corp. New | 0,63 % | 1,27 % | 1,27 % | 50,00 % | 1,92 % | 10,42 % | 6,71 % |
| MicroVision Inc | 5,23 % | -3,58 % | -7,76 % | -45,57 % | -26,37 % | -69,07 % | -96,34 % |
Kommentare
News
Federal Reserve Chairman Jerome Powell Just Delivered Fantastic News for Stock Market Investors
Ongoing geopolitical tensions in the Middle East have triggered a surge in oil prices, stoking fears of an inflation spike that could derail the U.S. economy. The last time inflation suddenly
Better Buy: Bitcoin vs. Ethereum
With Bitcoin (CRYPTO: BTC) down 47% from its all-time high of $126,000 just a few months ago, it's perhaps no surprise that crypto investors are starting to look elsewhere for opportunities.
For
Harvard University's Investment Manager Loads Up On 3.87M ETHA Shares
According to a SEC filing dated Feb. 13, 2026, Harvard Management Co. Inc. established a new position in the iShares Ethereum Trust ETF (NASDAQ:ETHA), acquiring 3,870,900 shares. The estimated




